In this video, Julius Wilder, MD, PhD, discusses early results from the ongoing phase 2 ELMWOOD open-label extension trial of elafibranor in patients with primary sclerosing cholangitis.“Some of the ...

Primary sclerosing cholangitis is an idiopathic, heterogeneous, cholestatic liver disease that is characterized by persistent, progressive, biliary inflammation and fibrosis. There is no effective ...

Keep abreast with the latest news related to Sclerosing Cholangitis there are 143 news items on Sclerosing Cholangitis that covers updates, breakthroughs and in-depth reports. We provide you with a ...

Autoimmune features negatively influenced pediatric sclerosing cholangitis, but concomitant inflammatory bowel disease did not, according to a recently published study. “Pediatric sclerosing ...

Although PSC has no cure, you can manage liver damage with early diagnosis and treatment. Here’s how PSC and UC are connected, and what you can do if you have both. Like UC, PSC is a chronic ...

Sclerosing cholangitis and primary biliary cirrhosis, which is now called primary biliary cholangitis (PBC), are chronic cholestatic liver diseases, but they differ in their causes, affected bile ...

Findings indicate blood group A elevates the risk of primary biliary cholangitis, suggesting ABO group analysis could aid in ...

Secondary sclerosing cholangitis (SSC) is a chronic cholestatic biliary disease, characterized by inflammation, obliterative fibrosis of the bile ducts, stricture formation and progressive destruction ...

Primary biliary cholangitis (PBC) and Primary sclerosing cholangtiis (PSC) are both progressive bile duct-related liver diseases, with similar symptoms and effects. Both diseases cause the gradual ...

Primary sclerosing cholangitis (PSC) is a disease that affects your bile ducts. Bile is a digestive fluid your Liver makes. The ducts let it flow from your liver to your gallbladder and finally to ...